相关实验视频

Updated: May 6, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

费混合物通过调节NR1D1-介导的免疫细胞透来对抗非小细胞肺癌发挥抗瘤活性

Haiyong Wang¹, Lingsun Guo², Yu Zhao³

¹Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Advanced biology

|February 23, 2026

概括

费混合物 (FWHJ) 通过激活NR1D1,通过cGAS-STING通路增强抗瘤免疫力并抑制JAK-STAT3信号传递来抑制非小细胞肺癌 (NSCLC). 这揭示了FWHJJ.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

费混合物 (FWHJ) 是用于肺癌的医院制剂,作用机制不明.
了解FWHJ的分子点对于优化肺癌治疗至关重要.

研究的目的:

阐明FWHJ在非小细胞肺癌 (NSCLC) 中的抗瘤机制.
研究NR1D1,cGAS-STING和JAK-STAT3信号在FWHJ治疗效果中的作用.

主要方法:

使用了患有易斯肺癌 (LLC) 瘤的小鼠和LCL-CD8+ T细胞共同培养模型.
西部斑块,流细胞计和免疫试验评估了瘤生长,T细胞透,细胞亡和关键信号分子.
采用NR1D1淘汰模型来证实它的作用.

主要成果:

在体内,FWHJ剂量依赖地抑制了瘤生长,并增强了CD4+/CD8+ T细胞的透.
在FWHJ上调节NR1D1,SOCS3和cGAS-STING通路,同时抑制JAK-STAT3信号.
NR1D1淘汰赛取消了FWHJ的抗瘤作用,证实了其至关重要的作用.

结论:

通过激活NR1D1,刺激cGAS-STING通路,并抑制JAK-STAT3信号,FWHJ具有抗NSCLC的作用.
这种机制增强了抗瘤免疫力,为肺癌治疗中FWHJ提供了科学依据.

关键词:

这就是NR1D1的特点.在SOCS3-JAK-STAT3中使用.cGAS-STING 的使用情况.菲威混合物混合物非小细胞肺癌的肺癌.

更多相关视频

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...